These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 27515451)

  • 1. CYP2B6 and OPRM1 Receptor Polymorphisms at Methadone Clinics And Novel OPRM1 Haplotypes: A Cross-Sectional Study.
    AlMeman AA; Ismail R; Perola M
    Drug Metab Lett; 2016; 10(3):213-218. PubMed ID: 27515451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences.
    Chawar C; Hillmer A; Lamri A; Kapczinski F; Thabane L; Pare G; Samaan Z
    PLoS One; 2021; 16(12):e0261201. PubMed ID: 34910759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OPRM1 genetic polymorphisms are associated with the plasma nicotine metabolite cotinine concentration in methadone maintenance patients: a cross sectional study.
    Chen YT; Tsou HH; Kuo HW; Fang CP; Wang SC; Ho IK; Chang YS; Chen CH; Hsiao CF; Wu HY; Lin KM; Chen ACh; Tsai-Wu JJ; Liu YL
    J Hum Genet; 2013 Feb; 58(2):84-90. PubMed ID: 23223006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interindividual variability in the prevalence of OPRM1 and CYP2B6 gene variations may identify drug-susceptible populations.
    Bunten H; Liang WJ; Pounder DJ; Seneviratne C; Osselton D
    J Anal Toxicol; 2011 Sep; 35(7):431-7. PubMed ID: 21871151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of genetic polymorphisms in ABCB1, CYP2B6, OPRM1, ANKK1 and DRD2 genes on methadone therapy in Han Chinese patients.
    Hung CC; Chiou MH; Huang BH; Hsieh YW; Hsieh TJ; Huang CL; Lane HY
    Pharmacogenomics; 2011 Nov; 12(11):1525-33. PubMed ID: 21902500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haplotype-Based Association and In Silico Studies of OPRM1 Gene Variants with Susceptibility to Opioid Dependence Among Addicted Iranians Undergoing Methadone Treatment.
    Tolami HF; Sharafshah A; Tolami LF; Keshavarz P
    J Mol Neurosci; 2020 Apr; 70(4):504-513. PubMed ID: 31853823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A brief review of the genetics and pharmacogenetics of opioid use disorders.
    Berrettini W
    Dialogues Clin Neurosci; 2017 Sep; 19(3):229-236. PubMed ID: 29302220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OPRM1 and CYP2B6 gene variants as risk factors in methadone-related deaths.
    Bunten H; Liang WJ; Pounder DJ; Seneviratne C; Osselton D
    Clin Pharmacol Ther; 2010 Sep; 88(3):383-9. PubMed ID: 20668445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study.
    Victorri-Vigneau C; Verstuyft C; Bouquié R; Laforgue EJ; Hardouin JB; Leboucher J; Le Geay B; Dano C; Challet-Bouju G; Grall-Bronnec M
    Br J Clin Pharmacol; 2019 Jul; 85(7):1538-1543. PubMed ID: 30907440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
    Yang HC; Chu SK; Huang CL; Kuo HW; Wang SC; Liu SW; Ho IK; Liu YL
    PLoS Genet; 2016 Mar; 12(3):e1005910. PubMed ID: 27010727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
    Zhang Q; Shi M; Tang H; Zhong H; Lu X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients.
    Wang SC; Tsou HH; Chen CH; Chen YT; Ho IK; Hsiao CF; Chou SY; Lin YF; Fang KC; Huang CL; Su LW; Fang YC; Liu ML; Wu HY; Lin KM; Liu SC; Kuo HW; Chiang IC; Chen AC; Tian JN; Liu YL
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):695-703. PubMed ID: 22406240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
    Oueslati B; Moula O; Ghachem R
    Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics biomarkers for personalized methadone maintenance treatment: The mechanism and its potential use.
    Ramli FF
    Bosn J Basic Med Sci; 2021 Apr; 21(2):145-154. PubMed ID: 32841585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenomics of methadone maintenance treatment.
    Somogyi AA; Barratt DT; Ali RL; Coller JK
    Pharmacogenomics; 2014 May; 15(7):1007-27. PubMed ID: 24956254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2B6 and OPRM1 gene variations predict methadone-related deaths.
    Bunten H; Liang WJ; Pounder D; Seneviratne C; Osselton MD
    Addict Biol; 2011 Jan; 16(1):142-4. PubMed ID: 21158011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics.
    Barratt DT; Coller JK; Hallinan R; Byrne A; White JM; Foster DJ; Somogyi AA
    Pharmgenomics Pers Med; 2012; 5():53-62. PubMed ID: 23226062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.